2021 Archive

Profiles

5 Questions for Sarada Achyutuni, PhD

LaToyia P. Downs, PhD and Sarada Achyutuni

Meet postdoctoral researcher Sarada Achyutuni, PhD, Center of Excellence for Leukemia Studies, and learn about her research.

Leukemia

AI-driven μPharma platform accurately predicts leukemia drug sensitivity

Brian O'Flynn, PhD

See how an artificial intelligence single-cell microfluidics pharmacotyping tool helps identify drugs for T-cell acute lymphoblastic leukemia

Outreach

Access to childhood cancer medicines grows trust and security in Zambia

Alex Generous, PhD

The Global Platform for Access to Childhood Cancer Medicines is growing trust to improve pediatric cancer treatment in Zambia

Investigator Insights

Shaping the future of qualitative research in pediatric medicine

LaToyia P. Downs, PhD and Jake Hopkins, MBA

Watch St. Jude experts discuss how qualitative research is shaping the future of pediatric medicine and improving patient-centered care.

Research

Center for Infectious Diseases Research takes aim at pediatric pathogens

Ashley DuMont, PhD

Learn how the Center for Infectious Diseases Research is facilitating collaborations across departments at St. Jude.

Outreach

Simulations help create real-world solutions to global health challenges

LaToyia P. Downs, PhD

Learn how the Global Disease Burden and Simulation Unit at St. Jude is making efforts to improve childhood cancer care worldwide.

Neurologic Disease

5 Questions for Joshua Burns, PhD

Joshua Burns, PhD and Alex Generous, PhD

Meet Joshua Burns, PhD, and learn about his work on Charcot-Marie-Tooth disease (CMT).

Clinical Research

Browsing tumor library sparks understanding of drug resistance in childhood kidney cancer

Brian O'Flynn, PhD

See how a patient-derived xenograft library is shaping Wilms tumor treatments.

Clinical Research

Targeted therapy improvements cap a decade of innovation in spinal muscular atrophy care

Brian O'Flynn, PhD

See how clinicians are working to bring the best SMA treatment to more patients.

Outreach

Using books to bring comfort amid the stress of clinical care

LaToyia P. Downs, PhD

Discover how the Books on Wheels initiative at St. Jude is bringing comfort and connection to patients through the power of reading.

Research

Identifying risks and restrictions: Rehabilitation and cancer survivorship

St. Jude Communications Department

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Research

Getting to the bottom of a medulloblastoma mystery

Erin Podolak, MA

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

Cancer Biology

NCCN publishes guidelines for standardized treatment of Wilms tumor

St. Jude Strategic Communication, Education and Outreach Department

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

Research

For the growing number of childhood cancer survivors, five-year survival is just the beginning

AnnaLynn Williams, PhD

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

Outreach

Advocating globally for a COVID-19 vaccine

Miguela Caniza, MD, MPH

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

Outreach

We can – we will – accelerate progress globally

James R. Downing, MD

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Research

The heart of the matter – cancer survivors and heart disease

Matthew J. Ehrhardt, MD

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Research

Immune markers offer clues to antibody production in response to flu

Mary Powers

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

Clinical

Cancer care during a pandemic: What we learned prepares us for the next emergency

Dylan Graetz, MD, MPH

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Clinical Research

Learning the value of mentors, champions and building a strong network

St. Jude Progress

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.